Biomedical Engineering Reference
In-Depth Information
[190] pan d, Caruthers sd, senpan A, Yalaz C, stacy AJ, Hu G, Marsh Jn, Gaffney pJ,
Wickline sA, Lanza GM. synthesis of nanoQ, a copper-based contrast agent for high-
resolution magnetic resonance imaging characterization of human thrombus. J Am
Chem soc 2011;
133
:9168-9171.
[191] Ward KM, Aletras AH, Balaban Rs. A new class of contrast agents for MRI based on
proton chemical exchange dependent saturation transfer (CesT). J Magn Reson
2000;
143
:79-87.
[192] Hancu I, dixon WT, Woods M, Vinogradov e, sherry Ad, Lenkinski Re. CesT and
pARACesT MR contrast agents. Acta Radiol 2010;
51
:910-923.
[193] Zhou J, payen J-F, Wilson dA, Traystman RJ, van Zijl pC. using the amide proton
signals of intracellular proteins and peptides to detect pH effects in MRI. nat Med
2003;
9
:1085-1090.
[194] Ling W, Regatte RR, navon G, Jerschow A. Assessment of glycosaminoglycan
concentration
in vivo
by chemical exchange-dependent saturation transfer (gagCesT).
proc natl Acad sci u s A 2008;
105
:2266-2270.
[195] Trokowski R, Ren J, Kálmán FK, sherry Ad. selective sensing of zinc ions with a
pARACesT contrast agent. Angew Chem Int ed engl 2005;
44
:6920-6923.
[196] pikkemaat JA, Wegh RT, Lamerichs R, van de Molengraaf RA, Langereis s, Burdinski
d, Raymond AYF, Janssen HM, de Waal BFM, Willard np, Meijer eW, Grüll H.
dendritic pARACesT contrast agents for magnetic resonance imaging. Contrast Media
Mol Imaging 2007;
2
:229-239.
Search WWH ::
Custom Search